Nanox Highlighted on TIME's Best Inventions of 2024 List for its AI Solutions
October 31 2024 - 8:00AM
NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an
innovative medical imaging technology company, today announced that
its deep-learning medical imaging analytics subsidiary, NanoxAI
Ltd. (Nanox AI), was selected for a Special Mention in the TIME’s
Best Inventions of 2024 list.
TIME’s annual Best Inventions list celebrates the
most groundbreaking products and ideas that are shaping industries
and enhancing lives. As noted by TIME, Nanox AI was highlighted as
one of the most impactful new products, using “AI to help identify
asymptomatic undetected chronic conditions early by analyzing
routine medical CT scans.”
“We are honored to receive this recognition from TIME,” said
Erez Meltzer, Nanox's Chief Executive Officer and Acting Chairman.
“This validates our AI technology's success in helping clinicians
detect early signs of chronic and acute diseases. As a leader in
end-to-end medical imaging innovation, we're committed to improving
patient outcomes through earlier detection and preventive
care.”
Nanox AI’s special mention can be viewed here: Nanox.AI
Solutions for Medical Imaging: the 200 Best Inventions of 2024 |
TIME
Nanox AI’s FDA-cleared solutions analyze routine CT scans
performed for any clinical indication to help identify patients
with findings correlated with chronic conditions in cardiac, liver
and bone, with the goal of promoting preventive care management.
These chronic conditions are often asymptomatic and previously
undetected in patients.
Nanox AI's following solutions have each received FDA 510(k)
clearance:
- AI Cardiac solution (HealthCCSng) measures calcified plaques in
the coronary arteries, which present a risk for coronary artery
disease.
- AI Bone solution (HealthOST) provides qualitative and
quantitative analysis of the spine from CT images to support
clinicians in the evaluation and assessment of musculoskeletal
disease of the spine.
- AI Liver solution (HealthFLD) provides quantitative and
qualitative analysis of the liver from CT images to support
clinicians in the evaluation and assessment of Fatty Liver.
About Nanox AI Nanox AI is the deep-learning
medical imaging analytics subsidiary of Nanox. Nanox AI’s solutions
are developed to target highly prevalent chronic and acute diseases
affecting large populations around the world. Leveraging AI
technology, Nanox AI helps clinicians extract valuable and
actionable clinical insights from routine medical imaging that
otherwise may go unnoticed, potentially initiating further medical
assessment to establish individual preventative care pathways for
patients. For more information, please visit
https://www.nanox.vision/ai.
About Nanox Nanox (NASDAQ: NNOX) is focused on
driving the world’s transition to preventive health care by
bringing a full solution of affordable medical imaging
technologies based on advanced AI and novel digital
source.
Nanox's vision encompasses expanding the reach of Nanox
technology both within and beyond hospital settings, providing a
seamless end-to-end solution from scan to diagnosis, leveraging AI
for smarter diagnostics and maintaining a clinically-driven
approach. The Nanox ecosystem includes Nanox.ARC – a multi-source
Digital Tomosynthesis system that is cost-effective and
user-friendly; Nanox.AI – an AI-based suite of algorithms that
augment the readings of routine CT imaging to highlight early signs
often related to chronic diseases; Nanox.CLOUD – a cloud-based
software platform that manages and stores data collected by Nanox
devices, and provides users with tools for in-depth imaging
analysis; Nanox.MARKETPLACE – a proprietary decentralized
marketplace through Nanox’s subsidiary, USARAD Holdings Inc.,
that provides remote access to radiology and cardiology experts,
and a comprehensive teleradiology services platform. By improving
early detection and treatment, Nanox aims to enhance its better
health outcomes worldwide. For more information, please visit
www.nanox.vision.
Contacts
Media Contact: Ben Shannon ICR Westwicke
NanoxPR@icrinc.com
Investor Contact: Mike Cavanaugh ICR Westwicke
mike.cavanaugh@westwicke.com
Nano X Imaging (NASDAQ:NNOX)
Historical Stock Chart
From Nov 2024 to Dec 2024
Nano X Imaging (NASDAQ:NNOX)
Historical Stock Chart
From Dec 2023 to Dec 2024